Stivarga and Novalgin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Stivarga (regorafenib) and Novalgin (metamizole). Common drug interactions include atrial flutter among females and fatigue among males.
The phase IV clinical study analyzes what interactions people have when they take Stivarga and Novalgin. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Stivarga?
Stivarga has active ingredients of regorafenib. eHealthMe is studying from 9,539 Stivarga users. Check the latest studies of Stivarga.
What is Novalgin?
Novalgin has active ingredients of metamizole. It is often used in pain. eHealthMe is studying from 10,177 Novalgin users. Check the latest studies of Novalgin.
13 people who take Stivarga and Novalgin together, and have interactions are studied.

What are the common drug interactions of Stivarga and Novalgin, by gender? *:
female:
- Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
- Cholecystitis (infection of gallbladder)
- Abdominal pain
- Back pain
- Bone marrow failure
- Diarrhoea
- Drug ineffective
- Infection
- Lymphoedema (localized fluid retention and tissue swelling)
- Nausea (feeling of having an urge to vomit)
male:
- Fatigue (feeling of tiredness)
- Hyperbilirubinaemia (excess of bilirubin in the blood)
- Dysphonia (speech disorder attributable to a disorder of phonation)
- Dyspnoea (difficult or laboured respiration)
- Infection
- Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
- Mucosal inflammation (infection of mucous membrane)
- Abdominal pain upper
- Ascites (accumulation of fluid in the abdominal cavity)
- Diarrhoea
What are the common drug interactions of Stivarga and Novalgin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Intestinal perforation (complete penetration of the wall of the intestine)
- Muscle abscess (pus in muscle)
- Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
- Renal failure chronic (long lasting kidney dysfunction)
50-59:
- Abdominal pain upper
- Ascites (accumulation of fluid in the abdominal cavity)
- Asthenia (weakness)
- Diarrhoea
- Fatigue (feeling of tiredness)
- General physical health deterioration (weak health status)
- Haemoglobin decreased
- Ocular icterus (presence of jaundice seen in the sclera of the eye)
- Oedema peripheral (superficial swelling)
- Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
60+:
- Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
- Cholecystitis (infection of gallbladder)
- Colorectal cancer metastatic (cancer of colon and rectal spreads to other parts)
- Cough
- Decreased appetite
- Diarrhoea
- Drug ineffective
- Dysphonia (speech disorder attributable to a disorder of phonation)
- Dyspnoea (difficult or laboured respiration)
- Fatigue (feeling of tiredness)
What are the existing conditions these people have? *
- Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 6 people, 46.15%
- Hepatocellular Carcinoma (liver cancer): 3 people, 23.08%
- Nausea (feeling of having an urge to vomit): 2 people, 15.38%
- Colon Cancer: 2 people, 15.38%
- Varices Oesophageal (enlarged and swollen veins at the bottom of the oesophagus, near the stomach): 1 person, 7.69%
- Gastrointestinal Stromal Tumor: 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Stivarga and Novalgin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Stivarga and Novalgin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Stivarga:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Novalgin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Stivarga and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Novalgin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on regorafenib and metamizole (the active ingredients of Stivarga and Novalgin, respectively), and Stivarga and Novalgin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lipoma and drugs of ingredients of alprazolam - 17 seconds ago
- Dovonex vs. Raptiva, side effect and effectiveness comparison - 32 seconds ago
- Could Norvasc cause Metastases To Pancreas? - 34 seconds ago
- Pneumonia and drugs of ingredients of bexarotene - 39 seconds ago
- Drug interactions of Pentasa and Para - 48 seconds ago
- Drug interactions of Otezla and Opana - 50 seconds ago
- Could Eprex cause Neoplasm Progression? - 50 seconds ago
- Drug interactions of Novolog and Provera - 53 seconds ago
- Percocet vs. Clonidine Hydrochloride, side effect and effectiveness comparison - 53 seconds ago
- Drug interactions of Zoladex and Zosyn - 54 seconds ago